Wed 25 Nov 2009 | 16:25 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For ImmunoGen, Inc.

ImmunoGen, Inc. (IMGN.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View IMGN on other exchanges
As of  3:51pm EST
8.34USD
Price Change
-0.04
Percent Change
-0.48%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
O'Leary, James 45 2008 Vice President, Chief Medical Officer
Williams, Peter 55 2009 Vice President - Business Development
Perry, Gregory 49 2009 Principal Financial Officer, Principal Accounting Officer, Senior Vice President
Junius, Daniel 57 2009 President, Chief Executive Officer
Carter, David 70 2002 Lead Director
Lambert, John 58 2008 Executive Vice President - Research and Development, Chief Scientific Officer
Sayare, Mitchel 61 2009 Director
Skaletsky, Mark 61 2000 Director
Villafranca, Joseph 65 2004 Director
Onetto, Nicole 56 2005 Director
Pien, Howard 51 2009 Director
Wallace, Richard 58 2007 Director
McCluski, Stephen 57 2009 Chairman of the Board